CHP investigates locally acquired measles case
The Centre for Health Protection (CHP) of the Department of Health (DH) today (June 5) is investigating a local measles case and reminds members of the public that vaccination is the most effective way to prevent measles.
The case involves a 19-year-old female who developed a fever, myalgia and headache on May 29. She attended a private clinic on the following day (May 30). As her symptoms persisted and she further developed a rash, she attended to the Accident and Emergency Department of Queen Elizabeth Hospital (QEH) on June 1. Her clinical specimen was tested positive for the measles virus upon laboratory testing. The patient is currently receiving treatment under isolation and is in stable condition.
An epidemiological investigation revealed that the patient was born outside Hong Kong. She reported having received the measles vaccination in her place of birth during childhood. As she spent most of her incubation period in Hong Kong, the case has been classified as a local case.
The patient is a student but she did not visit the school campus during the incubation period (between May 8 and 22) and the communicable period (between May 28 to June 5). During the communicable period, the patient visited a private clinic on May 30 and QEH on June 1. For the remainder of the communicable period, she largely remained alone at her residence. The CHP has contacted the abovementioned private clinic, the hospital and the residential management company to identify any close contacts and high risk individuals. As of 5pm today, approximately 85 individuals have been identified as close contacts. All of them are asymptomatic so far. The CHP will put the individuals under medical surveillance.
The CHP will continue to investigate and follow up on the case.
So far this year, eight measles cases have been recorded in Hong Kong, including four imported cases and four local cases (two of which were epidemiologically linked to an imported case and all of which belonged to the airport backend support staff cluster recorded earlier). In the past two years (2024 and 2025), 10 cases were recorded each year.
Measles outbreaks are currently occurring in many regions around the world. In recent years, North America (including the United States, Canada and Mexico) and Southeast Asia (including Indonesia, Cambodia and the Philippines) have seen persistent measles outbreaks due to low vaccination coverage. Nearly 2 000 cases have been recorded in the United States so far this year, a figure significantly higher than the same period last year. In Europe, the number of measles cases in the United Kingdom and Spain has increased this year, with 630 and 118 cases recorded respectively since January. In Asia, measles remains prevalent in the Philippines, Indonesia, Pakistan, Bangladesh and Cambodia. Japan has also seen a substantial rise in cases this year, with 511 cases recorded as of May 27, surpassing last year’s total of 265 cases and marking the highest record since 2019. Singapore and Australia have reported 37 and 104 measles cases respectively this year, which is also higher than the same period last year. Most of the overseas cases involved individuals who were not vaccinated against measles or had an unknown vaccination status, highlighting the importance of maintaining a high vaccination rate and herd immunity within the community.
As a city with a high volume of international travel, Hong Kong faces the potential risk of importation of the measles virus and its spread in the local community. The CHP’s territory-wide immunisation surveys showed that under the Hong Kong Childhood Immunisation Programme, the two-dose measles vaccination coverage has consistently stayed above 95 per cent. The local seroprevalence rates of measles virus antibodies reflect that most people in Hong Kong are immune to measles. However, measles is highly contagious. A small number of people who have not completed measles vaccinations (such as non-locally born people including new immigrants, foreign domestic helpers, overseas employees and people coming to Hong Kong for further studies) are still at risk of being infected and spreading measles to others without immunity against measles, such as children under one year old who have not yet received the first dose of the measles vaccine. Those who have unknown immunities against measles or need to receive measles vaccinations are urged to consult their doctor.
The Hong Kong Childhood Immunisation Programme introduced a measles vaccine for the first time in 1967. Thanks to the strong support of parents, schools and the healthcare sector, Hong Kong’s vaccination coverage has remained at a very high level, enabling the city to successfully eliminate measles in 2016. Over the past two years, measles outbreaks have occurred in many parts of the world, leading to a resurgence of community transmission in some countries that had previously eliminated the disease. However, because Hong Kong’s vaccination coverage has remained high, the number of cases recorded in the city has not risen significantly as a result, and Hong Kong has successfully maintained its measles-eliminated status to date.
People born and raised in Hong Kong before 1967 can be considered to have acquired immunity to measles through natural infection, as measles was endemic in Hong Kong at that time. People born in Hong Kong in or after 1967 who have not yet completed the two doses of measles vaccination, or whose measles vaccination history is unknown, should consult their family doctors as soon as possible to complete the vaccination and ensure adequate protection against measles.
The incubation period of measles (i.e. the time from infection to onset of illness) is seven to 21 days. Symptoms include fever, skin rash, cough, runny nose and red eyes. If travellers returning from places with a high incidence or an outbreak of measles develop symptoms of measles (e.g. fever and rash), they should seek medical advice immediately and avoid contact with non-immune individuals, especially pregnant women and infants under one year old. They should also report their symptoms and prior travel history to healthcare workers so that appropriate infection control measures can be implemented at the healthcare facilities to prevent any potential spread.
Besides being vaccinated against measles, members of the public should take the following measures to prevent infection:
For more information on measles, the public may visit the CHP’smeasles thematic page. Members of the public who are going to travel can visit the website of the DH’sTravel Health Servicefor news of measles outbreaks outside Hong Kong.
Source: AI-found images
CHP investigates confirmed Mpox case epidemiologically linked to “Hutong”
The Centre for Health Protection (CHP) of the Department of Health (DH) said today (June 5) that it is investigating a confirmed locally acquired Mpox (also known as Monkeypox) case epidemiologically linked to the two cases involving in “Hutong” announced on May 25. The CHP has been closely following up on the investigation, including attempting to contact individuals who visited the premises on or after May 1, providing them with health education and continuing to conduct medical surveillance. The CHP urged the public to be vigilant and avoid close physical contact with persons suspected of contracting Mpox. Meanwhile, high-risk target groups are advised to receive Mpox vaccinations.
Case details
—————
The case involves a 52-year-old male who reported to have high-risk contact at a premises called “Hutong” on Shanghai Street, Mong Kok, on May 2 (during the incubation period). He developed a non-pruritic and painless rash over his genital area on May 21, followed by a fever and sore throat on May 25, and a subsequent rash eruption over his upper limbs, chest, and anal region. The CHP made several attempts to contact the patient between the end of May and the beginning of June, but had failed to reach him. The CHP thus sent him a text message. The patient attended the Yau Ma Tei Male Social Hygiene Clinic on June 4 to seek medical treatment and reported relevant high-risk contact history to the healthcare workers. The CHP subsequently arranged for him to receive isolation treatment at the Yan Chai Hospital. The patient is currently in stable condition. His samples tested positive for Monkeypox virus upon laboratory testing by the Public Health Laboratory Services Branch of the CHP.
According to the information provided by the patient, he has not received Mpox vaccination. The CHP is continuing its epidemiological investigations of the case and endeavouring to contact individuals who had high-risk contact with him. The CHP will report the case to the World Health Organization.
Follow-up on the “Hutong” cases in Mong Kok
———————————————
The CHP continues to follow up on the investigation of the cases in “Hutong”, and has now successfully contacted around 300 persons who have visited the premises on or after May 1. No other cases have been identified so far. The CHP has provided them with health education and continued to conduct medical surveillance. The CHP again urges anyone who visited the premises on or after May 1 to call the CHP’s designated Mpox telephone hotline (2125 2373), so that the CHP can provide health assessments and advice. The hotline operates daily from 9am to 6pm. As investigations are still ongoing, the premises has been closed temporarily starting from May 26.
Furthermore, the CHP will collaborate with Hong Kong AIDS Foundation to launch an outreach Mpox vaccination activity in the next two weeks at the organisation’s service centre in Mong Kok. Eligible high-risk groups (especially men who have sex with men) can make an appointment on the organisation’s website.
Since 2022, Hong Kong has recorded a total of 88 Mpox cases (71 local cases and 17 imported cases), including the above-mentioned case. All patients were males. Epidemiological investigations revealed that most cases had history of high-risk sexual behaviour, including having sex with strangers or having sex without wearing condoms.
Mpox vaccine
—————–
Mpox vaccine can prevent infection and severe disease. The DH provides Mpox vaccination services for highrisk groups. The following high-risk target groups are eligible for Mpox vaccinations on a voluntary basis:
High-risk target groups can receive Mpox walk-in vaccinations at any of the DH’s SocHS (namely Chai Wan SocHS, Wan Chai Male SocHS, Wan Chai Female SocHS, Yau Ma Tei Male SocHS, Yau Ma Tei Female SocHS, Yung Fung Shee SocHS, Fanling SocHS and Tuen Mun SocHS) and the DH’s Yau Ma Tei Integrated Treatment Centre.
Meanwhile, the DH’s Kowloon Bay Integrated Treatment Centre and the Hospital Authority’s Special Medical Clinics at Queen Elizabeth Hospital and Princess Margaret Hospital also provide Mpox vaccination services for their clients.
Mpox is not transmitted through respiratory droplets or aerosols in general, and transmission would not occur through social contact. The CHP reminds the public, especially those at higher risks of exposure, to take precautions and avoid close physical contact with persons or animals suspected of infection. They should seek medical attention as soon as possible if they experience relevant symptoms, including rash, fever, chills, swollen lymph nodes, exhaustion, muscle pain, and severe headaches. They should not engage in activities with others that may involve contact with skin rash or body fluids.
For more details, please visit the CHP’s page onMpoxandMpox Vaccination Programme.
Source: AI-found images
